Abstract
Diabetes can impair osteoblastic functions and negatively interfere with osteointegration at the bone/implant interface. Previously, we prepared a nanosized calcium silicate (CS) incorporated-polyetheretherketone (PK) biocomposite (CS/PK) and found that the CS/PK composite exhibited enhanced osteoblast functions in vitro and osteointegration in vivo, but its bioperformance under diabetic conditions remained elusive. In this study, MC3T3-E1 cells incubated on CS/PK and PK samples were subjected to diabetic serum (DS) and normal serum (NS); cell attachment, morphology, spreading, proliferation, and osteogenic differentiation were compared to assess in vitro osteoblastic functions on the surfaces of different materials. An in vivo test was performed on diabetic rabbits implanted with CS/PK or PK implants into the cranial bone defect to assess the osteointegration ability of the implants. In vitro results showed that diabetes inhibited osteoblastic functions evidenced by impaired morphology and spreading, and decreased attachment, proliferation, and osteogenic differentiation compared with the findings under normal conditions. Notably, CS/PK ameliorated osteoblastic disfunction under diabetic conditions in vitro. In vivo results from micro-CT and histologic examinations revealed that rabbits with CS/PK implants exhibited improved osteointegration at the bone/implant interface under diabetic conditions compared with PK. Therefore, the CS/PK composite improved the impaired osteointegration induced by diabetes and is a promising orthopedic or craniofacial implant material that may obtain good clinical performance in diabetic patients.
Similar content being viewed by others
References
Annibali S, Pranno N, Cristalli MP, La Monaca G, Polimeni A. Survival analysis of implant in patients with diabetes mellitus: a systematic review. Implant Dent. 2016;25:663–74.
Javed F, Romanos GE. Impact of diabetes mellitus and glycemic control on the osseointegration of dental implants: a systematic literature review. J Periodontol. 2009;80:1719–30.
Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014;103:137–49.
Panayotov IV, Orti V, Cuisinier F, Yachouh J. Polyetheretherketone (PEEK) for medical applications. J Mater Sci. Mater M. 2016;27:118.
Ma R, Tang T. Current strategies to improve the bioactivity of PEEK. Int J Mol Sci. 2014;15:5426–45.
Luo H, Xiong G, Yang Z, Raman SR, Li Q, Ma C, et al. Preparation of three-dimensional braided carbon fiber-reinforced PEEK composites for potential load-bearing bone fixations. Part I. Mechanical properties and cytocompatibility. J Mech Behav Biomed. 2014;29:103–13.
Ma R, Yu Z, Tang S, Pan Y, Wei J, Tang T. Osseointegration of nanohydroxyapatite- or nano-calcium silicate-incorporated polyetheretherketone bioactive composites in vivo. Int J Nanomed. 2016;11:6023–33.
Ma R, Tang S, Tan H, Lin W, Wang Y, Wei J, et al. Preparation, characterization, and in vitro osteoblast functions of a nano-hydroxyapatite/polyetheretherketone biocomposite as orthopedic implant material. Int J Nanomed. 2014;9:3949–61.
No YJ, Li JJ, Zreiqat H. Doped calcium silicate ceramics: a new class of candidates for synthetic bone substitutes. Materials. 2017;10:153.
Zakaria MY, Sulong AB, Muhamad N, Raza MR, Ramli MI. Incorporation of wollastonite bioactive ceramic with titanium for medical applications: an overview. Mat Sci Eng. C-Mater. 2019;97:884–95.
Mohammadi H, Sepantafar M. Ion-doped silicate bioceramic coating of Ti-based implant. Iran Biomed J. 2016;20:189–200.
Ma R, Tang S, Tan H, Qian J, Lin W, Wang Y, et al. Preparation, characterization, in vitro bioactivity, and cellular responses to a polyetheretherketone bioactive composite containing nanocalcium silicate for bone repair. ACS Appl Mater Inter. 2014;6:12214–25.
King S, Klineberg I, Levinger I, Brennan-Speranza TC. The effect of hyperglycaemia on osseointegration: a review of animal models of diabetes mellitus and titanium implant placement. Arch Osteoporos. 2016;11:29.
Ma XY, Feng YF, Ma ZS, Li X, Wang J, Wang L, et al. The promotion of osteointegration under diabetic conditions using chitosan/hydroxyapatite composite coating on porous titanium surfaces. Biomaterials. 2014;35:7259–70.
Xiang G, Huang X, Wang T, Wang J, Zhao G, Wang H, et al. The impact of sitagliptin on macrophage polarity and angiogenesis in the osteointegration of titanium implants in type 2 diabetes. Biomed Pharmacother. 2020;126:110078.
Ma XY, Wen XX, Yang XJ, Zhou DP, Wu Q, Feng YF, et al. Ophiopogonin D improves osteointegration of titanium alloy implants under diabetic conditions by inhibition of ROS overproduction via Wnt/beta-catenin signaling pathway. Biochimie. 2018;152:31–42.
Wang L, Hu X, Ma X, Ma Z, Zhang Y, Lu Y, et al. Promotion of osteointegration under diabetic conditions by tantalum coating-based surface modification on 3-dimensional printed porous titanium implants. Colloid Surface B. 2016;148:440–52.
Ma XY, Feng YF, Wang TS, Lei W, Li X, Zhou DP, et al. Involvement of FAK-mediated BMP-2/Smad pathway in mediating osteoblast adhesion and differentiation on nano-HA/chitosan composite coated titanium implant under diabetic conditions. Biomater Sci. 2017;6:225–38.
Motyl KJ, Raetz M, Tekalur SA, Schwartz RC, McCabe LR. CCAAT/enhancer binding protein β-deficiency enhances type 1 diabetic bone phenotype by increasing marrow adiposity and bone resorption. Am J Physiol-Reg I. 2011;300:R1250–60.
Fan Q, Tang T, Zhang X, Dai K. The role of CCAAT/enhancer binding protein (C/EBP)-alpha in osteogenesis of C3H10T1/2 cells induced by BMP-2. J Cell Mol Med. 2009;13:2489–505.
Ramanathan T, Morita S, Huang Y, Shirota K, Nishimura T, Zheng X, et al. Glucose-insulin-potassium solution improves left ventricular energetics in chronic ovine diabetes. Ann Thorac Surg. 2004;77:1408–14.
Ruhé PQ, Kroese-Deutman HC, Wolke JGC, Spauwen PHM, Jansen JA. Bone inductive properties of rhBMP-2 loaded porous calcium phosphate cement implants in cranial defects in rabbits. Biomaterials. 2004;25:2123–32.
Kokubo T, Takadama H. How useful is SBF in predicting in vivo bone bioactivity? Biomaterials. 2006;27:2907–15.
Hu XF, Wang L, Xiang G, Lei W, Feng YF. Angiogenesis impairment by the NADPH oxidase-triggered oxidative stress at the bone-implant interface: Critical mechanisms and therapeutic targets for implant failure under hyperglycemic conditions in diabetes. Acta Biomater. 2018;73:470–87.
de Souza Bastos A, Graves DT, de Melo Loureiro AP, Júnior CR, Corbi SCT, Frizzera F, et al. Diabetes and increased lipid peroxidation are associated with systemic inflammation even in well-controlled patients. J Diabetes Complicat. 2016;30:1593–9.
Jiao H, Xiao E, Graves DT. Diabetes and its effect on bone and fracture healing. Curr Osteoporos Rep. 2015;13:327–35.
Liu X, Tan N, Zhou Y, Wei H, Ren S, Yu F, et al. Delivery of antagomiR204-conjugated gold nanoparticles from PLGA sheets and its implication in promoting osseointegration of titanium implant in type 2 diabetes mellitus. Int J Nanomed. 2017;12:7089–101.
Jiating L, Buyun J, Yinchang Z. Role of metformin on osteoblast differentiation in type 2 diabetes. BioMed Res Int. 2019;2019:9203934.
Dong X, Wang X, Xing M, Zhao C, Guo B, Cao J, et al. Inhibition of the negative effect of high glucose on osteogenic differentiation of bone marrow stromal cells by silicon ions from calcium silicate bioceramics. Regen Biomater. 2020;7:9–17.
Li B, Bian X, Hu W, Wang X, Li Q, Wang F, et al. Regenerative and protective effects of calcium silicate on senescent fibroblasts induced by high glucose. Wound Repair Regen. 2020;28:315–25.
Li H, Zhai W, Chang J. Effects of wollastonite on proliferation and differentiation of human bone marrow-derived stromal cells in PHBV/wollastonite composite scaffolds. J Biomater Appl. 2009;24:231–46.
Gotz W, Tobiasch E, Witzleben S, Schulze M. Effects of silicon compounds on biomineralization, osteogenesis, and hard tissue formation. Pharmaceutics. 2019;11:117.
Han P, Wu C, Xiao Y. The effect of silicate ions on proliferation, osteogenic, differentiation and cell signalling pathways (WNT and SHH) of bone marrow stromal cells. Biomater Sci. 2013;1:379–92.
Albrektsson T, Johansson C. Osteoinduction, osteoconduction and osseointegration. Eur Spine J. 2002;10:S96–S101.
Liu X, Ding C, Chu PK. Mechanism of apatite formation on wollastonite coatings in simulated body fluids. Biomaterials. 2004;25:1755–61.
Anderson JM, Rodriguez A, Chang DT. Foreign body reaction to biomaterials. Semin Immunol. 2008;20:86–100.
Bridges AW, García AJ. Anti-inflammatory polymeric coatings for implantable biomaterials and devices. J Diabetes Sci Technol. 2008;2:984–94.
Xu X, Li Y, Wang L, Li Y, Pan J, Fu X, et al. Triple-functional polyetheretherketone surface with enhanced bacteriostasis and anti-inflammatory and osseointegrative properties for implant application. Biomaterials. 2019;212:98–114.
Gao A, Liao Q, Xie L, Wang G, Zhang W, Wu Y, et al. Tuning the surface immunomodulatory functions of polyetheretherketone for enhanced osseointegration. Biomaterials. 2020;230:119642.
Lee BN, Hong JU, Kim SM, Jang JH, Chang HS, Hwang YC, et al. Anti-inflammatory and osteogenic effects of calcium silicate-based root canal sealers. J Endodont. 2019;45:73–8.
Acknowledgements
The authors would like to acknowledge the support from the National Natural Science Foundation of China (No. 81702130), Natural Science Foundation of Shaanxi Province (No. 2019JQ-143) and the Fundamental Research Funds for the Central Universities.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ma, R., Li, Y., Wang, J. et al. Incorporation of nanosized calcium silicate improved osteointegration of polyetheretherketone under diabetic conditions. J Mater Sci: Mater Med 31, 98 (2020). https://doi.org/10.1007/s10856-020-06435-0
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10856-020-06435-0